Healthcare stocks in the S&P 500 are up just 4.8% for the year, compared to the S&P 500's 15.9% gain.

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

Forbes Asia’s 2025 list has the most number of companies from India (18) followed by Singapore and Japan (14 each), China (9) ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy. On October 17, Tonix Pharmaceuticals (NASDAQ:TNXP) presented encouraging preclinical data for ...

A record 1,434 individuals, each with a net worth of more than US$700 million, have made it onto Hurun's list of China's richest people ...

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Duopharma Biotech Berhad (KLSE:DPHARMA) as an investment opportunity by projecting its future cash ...

That peer is Avidity Biosciences, which has agreed to be purchased by pharmaceutical giant Novartis in a deal that values the company at $12 billion. Novartis is paying a premium of 42% for Avidity's ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks. In this wonky industry, encouraging results from a clinical trial can turn ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

The stock makes the Nasdaq top gainers list today on news of Commercial Sales and Fulfillment of First Orders for Arbli. The stock is trading at $1.3200, +0.7485, gaining over 129% on volume of over ...

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands ...